MDY vs XLV
SPDR S&P MidCap 400 ETF Trust vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.23% for MDY.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | MDY | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.23% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.05% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $25.95B | $49.10B |
YTD return | 13.32% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.41 |
P/E ratio | 20.15 | 30.63 |
Last price | $681.87 | $187.94 |
Inception | — | — |
Issuer | State Street | State Street |
MDY top holdings
| TWLO | Twilio Inc Class A | 1.33% |
| OKTA | Okta Inc Class A | 1.03% |
| FTI | TechnipFMC PLC | 0.79% |
| NVT | nVent Electric PLC | 0.77% |
| ATI | ATI Inc | 0.76% |
| ENTG | Entegris Inc | 0.69% |
| UTHR | United Therapeutics Corp | 0.69% |
| XPO | XPO Inc | 0.61% |
| THC | Tenet Healthcare Corp | 0.61% |
| SNX | TD Synnex Corp | 0.61% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About MDY
MDY (SPDR S&P MidCap 400 ETF Trust) is Tracks the S&P MidCap 400 index. Managed by State Street, the fund carries $25.9B in assets under management, an expense ratio of 0.23%, a dividend yield of 1.05%. Its largest holding is Twilio Inc Class A (TWLO), which represents 1.3% of the portfolio. Real Estate is the fund's largest sector exposure at 7.8%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.